Novo Nordisk A/S

History

Year	Detail
1923	The company was founded.
1930	Production of insulin at Nordisk Insulinlaboratorium.
1946	NPH (Neutral Protamine Hagedorn) insulin was developed.
1951	Harald and Thorvald Pedersen founded the Novo Foundation.
1969	Novo opened a production plant in Kalundborg, Denmark.
1985	NovoPen was launched as the first insulin pen device.
1989	Novo and Nordisk foundations merged and recognized as Novo Nordisk AS.
2014	Partnership with UNICEF working together to prevent childhood overweight and obesity by creating healthier environments for children.
2023	Novo Nordisk and Life Edit Therapeutics established collaboration to discover and develop gene-editing therapies.
2024	Novo Nordisk collaborates with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.